Published:  Jan 26, 2016DOI: 10.7324/JAPS.2016.600125
Breast cancer is a commonly encountered cancer in women. Tamoxifen is a frequently used drug in breast cancer. It is a selective estrogen receptor modulator (SERM). It is used for both chemoprevention and for palliative care in these patients. Drug-induced thrombocytopenia is a common diagnosis these days. Moreover, this condition can be life threatening or even fatal. It can either be due to increased platelet destruction or reduced formation. Either way, early diagnosis followed by discontinuation of the offending agent is the key to successful management. Here, we present a rare case of tamoxifen-induced thrombocytopenia.
Pathak A, Kunder SK, Avinash A, Patil N, Rao NK. A Rare Case of Tamoxifen-Induced Thrombocytopenia. J App Pharm Sci, 2016; 6 (01): 156-157.
374 Absract views 6 PDF Downloads 380 Total views